Concurrent Review Documentation: How to Justify Continued Therapy

What Is a Concurrent Review?

A concurrent review is an insurance company's mid-treatment evaluation of whether ongoing mental health services continue to meet the criteria for medical necessity. Unlike a prior authorization, which occurs before treatment begins, a concurrent review takes place while the client is actively receiving care. The insurer's clinical reviewer examines your documentation to determine whether additional sessions should be authorized.

Concurrent reviews are typically triggered at specific intervals defined by the insurance plan, such as after every 8, 12, or 20 sessions, or when the total number of authorized sessions is about to be exhausted. Some plans use a case management model where a designated reviewer monitors treatment progress on an ongoing basis.

The concurrent review process may involve a written submission of clinical documentation, a telephone call with a utilization review clinician, completion of a standardized review form, or submission of recent progress notes and the current treatment plan. The reviewer evaluates whether the client continues to have a qualifying diagnosis with active symptoms, whether those symptoms cause functional impairment that requires professional treatment, whether the current treatment approach is appropriate and effective, and whether the client has achieved the treatment plan goals or still requires continued intervention.

Understanding how concurrent reviews work and preparing thorough documentation is essential for preventing interruptions in client care.

When You Need It

Concurrent review documentation is required in these scenarios:

• Scheduled review intervals. Most managed care plans have built-in review points. When you receive notification that a review is due, you must submit documentation within the specified timeframe, typically 5 to 10 business days.
• Approaching session limits. When the client is nearing the end of their authorized sessions, you must proactively request reauthorization with supporting documentation.
• Insurer-initiated review. Some insurers trigger reviews based on cost thresholds, diagnostic codes, or treatment duration. You may receive an unexpected request for clinical information at any time during treatment.
• Step-down or level of care change. If the client has improved significantly, the insurer may request documentation to determine whether a less intensive level of care (such as biweekly instead of weekly sessions) is appropriate.
• Treatment exceeding expected duration. If treatment extends beyond the typical duration for the client's diagnosis and presenting problems, additional justification is required.

Key Components

A concurrent review response must address the following areas comprehensively:

1. Current diagnosis with supporting symptoms. The active ICD-10 diagnosis with a list of current symptoms that continue to meet diagnostic criteria.
2. Functional impairment status. Specific, measurable descriptions of how the diagnosis continues to impair the client's functioning across life domains.
3. Treatment progress summary. A narrative of the client's trajectory from intake to the present, including objective measures showing improvement, stability, or areas of continued difficulty.
4. Current treatment plan goals. The specific, measurable goals being addressed, with status updates indicating which goals have been met, which are in progress, and which have been added or modified.
5. Interventions being used. Named, evidence-based interventions that are appropriate for the diagnosis and linked to treatment plan goals.
6. Justification for continued treatment. A clear statement of why the client cannot be safely discharged, stepped down, or transferred to a lower level of care at this time.
7. Discharge criteria and timeline. The specific criteria that must be met for treatment to be complete, with an estimated number of additional sessions needed.

How to Write It Step by Step

Step 1: Gather your clinical data before beginning. Before writing the concurrent review response, compile the client's intake assessment scores, most recent outcome measure scores, current treatment plan with goal status, and the last three to four progress notes. Having this data at hand ensures your response is accurate and thorough.

Step 2: Present the diagnosis with current symptom evidence. List the active diagnosis or diagnoses with the specific symptoms the client currently exhibits. Make it clear that the client continues to meet diagnostic criteria. If symptoms have partially remitted, note which criteria are still met and which have improved.

Step 3: Quantify functional impairment across all affected domains. Use concrete, measurable examples rather than general statements. Instead of "occupational impairment," write "client has declined a required work travel assignment and avoids in-person meetings, which his supervisor has identified as performance concerns." Compare current functioning to the client's pre-condition baseline whenever possible.

Step 4: Show the treatment trajectory. Present a clear picture of progress from intake to the present using objective data points. This shows the reviewer that treatment is working but is not yet complete. A client who has improved from a PCL-5 of 62 to 38 is clearly benefiting from treatment, but the score remains above the clinical threshold, which justifies continuation.

Step 5: Update each treatment plan goal with measurable status. For each goal, state the target, the current status, and the direction of change. Use language like "in progress," "partially met," or "not yet addressed with clinical rationale." This demonstrates active, goal-directed treatment rather than open-ended therapy.

Step 6: State what would happen without continued treatment. Reviewers need to understand the risk of discontinuation. Reference clinical literature when relevant: premature termination of CPT is associated with poorer outcomes, early remission from substance use disorders is a high-risk period, or the client has a documented history of relapse following prior treatment discontinuation.

Step 7: Provide clear discharge criteria and a timeline. Specify exactly what must happen for treatment to be considered complete, and estimate how many sessions are needed to reach those benchmarks. This demonstrates that treatment has a planned endpoint and is not indefinite.

Common Mistakes

Submitting documentation late. Concurrent reviews have strict deadlines. If you miss the submission window, sessions may not be authorized retroactively. Calendar all review dates when you receive authorization and begin preparing documentation at least one week before the deadline.

Focusing on progress without documenting remaining impairment. Paradoxically, demonstrating that the client has improved significantly can lead to denial if you do not also clearly document the functional impairments that persist. Balance your progress narrative with explicit descriptions of what the client still cannot do.

Not using objective outcome measures. Reviewers give far more weight to standardized scores than to clinical narrative alone. If you state that the client has "significant PTSD symptoms" without a PCL-5 score to back it up, the reviewer may not find the justification sufficient. Administer validated measures consistently and report the scores.

Presenting vague treatment goals. Goals like "improve coping skills" or "process trauma" are too vague for concurrent review. Each goal should be measurable and time-bound: "Reduce PCL-5 score from 38 to below 31 within 12 sessions." Vague goals make it impossible for the reviewer to evaluate progress.

Failing to request a peer-to-peer review after denial. If your concurrent review results in a denial of additional sessions, you have the right to a peer-to-peer conversation with a licensed clinician. Many denials are overturned during peer review because the treating clinician can provide context that written documentation does not fully capture. Always request this review before accepting a denial.

Not documenting the clinical rationale for treatment frequency. If you are seeing a client weekly and the reviewer believes biweekly would be sufficient, you need documentation supporting why weekly sessions are necessary. Reference the severity of symptoms, the treatment protocol requirements, and the risk of decompensation between sessions.